Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 GuidanceGlobeNewsWire • 02/22/23
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance SystemGlobeNewsWire • 02/16/23
Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023GlobeNewsWire • 02/03/23
First Patient Enrolled in Merit Medical's Multicenter Observational Study to Evaluate the Use of EmboCube® Embolization Gelatin to Control Bleeding or HemorrhageGlobeNewsWire • 12/05/22
Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers AssociationGlobeNewsWire • 11/22/22
Summary Notice to Current Merit Medical Systems, Inc. Stockholders of Derivative Action and Settlement HearingGlobeNewsWire • 11/02/22
Merit Medical Announces the Appointment of Joe Wright to Chief Commercial OfficerGlobeNewsWire • 11/01/22
Merit Medical Systems, Inc. (MMSI) Fred Lampropoulos on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 10/27/22